Humana Inc.

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse Other stock markets 02:30:03 13/01/2026 am IST			5-day change	1st Jan Change
276.59 ^USD	-0.09%		+0.29%	+7.99%

07:35pm	CenterWell - to dispense Lilly obesity medications in employer program	RE
08/01	Wolfe Adjusts Price Target on Humana to $325 From $300, Maintains Outperform Rating	MT

Humana Inc. Provides Earnings Guidance for the Year Ending December 31, 2022

Published on 07/27/2022 at 04:28 pm IST

S&P Capital IQ

Humana Inc.

-0.09%

Humana Inc. provided earnings guidance for the year ending December 31, 2022. For the period, the company expects GAAP diluted earnings per common share of approximately $20.30.

Latest news about Humana Inc.

07:35pm	CenterWell - to dispense Lilly obesity medications in employer program	RE
08/01	Wolfe Adjusts Price Target on Humana to $325 From $300, Maintains Outperform Rating	MT
07/01	Geopolitics Tests the Rally
07/01	Wells Fargo Downgrades Humana to Equalweight From Overweight, Price Target is $290	MT
07/01	Analyst recommendations: Amcor, Bank of America, Block, Crocs, Humana…
18/12	Pentagon awards Humana a $7.3 billion health care deal	RE
17/12	Morgan Stanley Cuts Price Target on Humana to $262 From $277, Maintains Equalweight Rating	MT
16/12	Wall St slips on losses in healthcare stocks, focus on 'distorted' economic data	RE
16/12	Humana reaffirms FY 2025 guidance of $12.26 EPS	RE
16/12	Humana Inc. Announces Executive Changes	CI
12/12	Humana Inc. entered into an agreement to acquire Familiehjelpgruppen As.	CI
11/12	Baird Adjusts Price Target on Humana to $264 From $280, Maintains Neutral Rating	MT
06/12	Sector Update: Health Care Stocks Lower Late Afternoon	MT
06/12	Sector Update: Health Care	MT
06/12	Humana Shares Rise After Upgrade From Jefferies	MT
05/12	The Most Overhyped PCE Print in Wall Street History
05/12	Analyst recommendations: Humana, Newmont, Robert Half, Apple, Macy's…
05/12	Jefferies Upgrades Humana to Buy From Hold, Adjusts Price Target to $313 From $253	MT
05/12	Sector Update: Health Care Stocks Slide Late Afternoon	MT
05/12	Humana Exploring Pharmacy Partnership With Mark Cuban	MT
26/11	Sector Update: Health Care Stocks Gain Late Afternoon	MT
26/11	Sector Update: Health Care Stocks Gain Tuesday Afternoon	MT
25/11	Sector Update: Health Care	MT
25/11	Humana Starts Appeal of October Ruling on Medicare Bonus Cuts	MT
24/11	Barclays Adjusts Price Target on Humana to $234 From $245, Maintains Equalweight Rating	MT

Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).

Employees

65,680

Sector

Managed Healthcare

Calendar

11/02 - Q4 2025 Earnings Release

More about the company